MedTrace Logo

Studying Genes to Identify Melanoma in Patients in Iceland and Their Family Members

NCT00346008 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2500

Last updated 2013-05-30

No results posted yet for this study

Summary

RATIONALE: Studying the genes expressed in samples of blood from patients with cancer and their family members may help doctors identify biomarkers related to cancer.

PURPOSE: This clinical trial is studying genes to identify melanoma in patients in Iceland and their family members.

Conditions

  • Melanoma (Skin)

Interventions

GENETIC

mutation analysis

OTHER

high performance liquid chromatography

OTHER

laboratory biomarker analysis

OTHER

questionnaire administration

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Iceland Genomics Corporation

    lead INDUSTRY

Principal Investigators

  • Alisa Goldstein, PhD · National Cancer Institute (NCI)

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-10-31
Primary Completion
2008-12-31
Completion
2009-02-28

Countries

  • Iceland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00346008 on ClinicalTrials.gov